Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115093132 | 11509313 | 2 | F | 20150512 | 20160830 | 20150915 | 20160909 | EXP | CH-GALDERMA-CH15005988 | GALDERMA | 33.00 | YR | F | Y | 0.00000 | 20160909 | OT | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115093132 | 11509313 | 1 | PS | DIFFERIN | ADAPALENE | 1 | Topical | 20748 | 1 | DF | CREAM | ||||||||
| 115093132 | 11509313 | 2 | SS | TETRALYSAL | LYMECYCLINE | 1 | Oral | 0 | 300 | MG | CAPSULE | QD | |||||||
| 115093132 | 11509313 | 3 | SS | SEBOLOX | MICONAZOLE NITRATE | 1 | Topical | 0 | 1 | DF | SHAMPOO | QOD | |||||||
| 115093132 | 11509313 | 4 | SS | ASCORBIC ACID. | ASCORBIC ACID | 1 | Topical | 0 | 1 | DF | |||||||||
| 115093132 | 11509313 | 5 | SS | HYDROQUINONE. | HYDROQUINONE | 1 | Topical | 0 | 1 | DF | |||||||||
| 115093132 | 11509313 | 6 | SS | TRETINOIN. | TRETINOIN | 1 | Topical | 0 | 1 | DF | |||||||||
| 115093132 | 11509313 | 7 | SS | DEXAMETHASON | DEXAMETHASONE | 1 | Topical | 0 | 1 | DF | |||||||||
| 115093132 | 11509313 | 8 | C | LUBEX | 2 | Topical | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115093132 | 11509313 | 1 | Acne |
| 115093132 | 11509313 | 2 | Product used for unknown indication |
| 115093132 | 11509313 | 3 | Product used for unknown indication |
| 115093132 | 11509313 | 4 | Skin hyperpigmentation |
| 115093132 | 11509313 | 5 | Skin hyperpigmentation |
| 115093132 | 11509313 | 6 | Skin hyperpigmentation |
| 115093132 | 11509313 | 7 | Skin hyperpigmentation |
| 115093132 | 11509313 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115093132 | 11509313 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115093132 | 11509313 | Exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115093132 | 11509313 | 1 | 20150512 | 20150530 | 0 | |
| 115093132 | 11509313 | 2 | 20150521 | 20150616 | 0 | |
| 115093132 | 11509313 | 3 | 20150521 | 20150616 | 0 | |
| 115093132 | 11509313 | 4 | 20150528 | 20150616 | 0 | |
| 115093132 | 11509313 | 5 | 20150528 | 20150616 | 0 | |
| 115093132 | 11509313 | 6 | 20150528 | 20150616 | 0 | |
| 115093132 | 11509313 | 7 | 20150528 | 20150616 | 0 | |
| 115093132 | 11509313 | 8 | 20150421 | 20150616 | 0 |